DK: Vi arbejder med precisions medicin ved gastrointestinal cancer, her med specielt fokus på stråleterapi ved rectum og anal cancer samt klinisk anvendelse af cirkulerende DNA og andre biomarkører.
UK: We work with precision medicine at gastrointestinal cancer, especially focusing on radiotherapy at the rectum and anal cancer and clinical use of circulating DNA and other biomarkers.
Workgroups Publications- Hypoxia and local tumour control in squamous cell carcinoma of the anus - a hypothesis-generating study Acta Oncol . 2022 Jun 22;1-4 2022
- Circulating tumor DNA as a marker of minimal residual disease following local treatment of metastases from colorectal cancer. Acta Oncol. 2020 Aug 13;1-6. 2020
- Measurement of circulating free DNA in squamous cell carcinoma of the anus and relation to risk factors and recurrence. Radiother Oncol . 2020 Jul 3;150:211-216. 2020
- Metastasis directed treatment of brain metastases from colorectal cancer - a Danish population-based cohort study. Acta Oncol . 2020 Sep;59(9):1118-1122. 2020
- Metastasis directed therapy for liver and lung metastases from colorectal cancer-A population-based study. Int J Cancer. 2018 Dec 15;143(12):3218-3226. 2018
- Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer. Clin Chim Acta. 2018 Dec;487:107-111. 2018
- Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy Clin Transl Radiat Oncol. 2022 Jun 8;36:9-15 2022
- Definitive therapy for squamous cell carcinoma of the anus with synchronous metastases - a report from the Danish Anal Cancer Group Acta Oncol . 2022 Mar;61(3):321-327 2022
- Intensified Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Anus-A Population-Based Experience from the Danish Anal Cancer Group ancers (Basel) . 2021 Jun 28;13(13):3226 2021
- The Clinical Value of Measuring Circulating HPV DNA during Chemo-Radiotherapy in Squamous Cell Carcinoma of the Anus Cancers (Basel) . 2021 May 18;13(10):2451 2021
- Anorectal function and radiation dose to pelvic floor muscles after primary treatment for anal cancer Radiother Oncol . 2021 Apr;157:141-146 2021
- Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancer. Ann Oncol. 2018 Mar 1;29(3):610-615 2018
- Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer - A multicentre dose planning study. Tech Innov Patient Support Radiat Oncol. 2019 Oct 15;11:14-21 2019
- Cell-free DNA and preoperative chemoradiotherapy for rectal cancer: a systematic review Clin Transl Oncol. 2019 Jul;21(7):874-880 2019
- Pelvic insufficiency fractures, dose volume parameters and plan optimization after radiotherapy for rectal cancer. Clin Transl Radiat Oncol. 2019 Sep 10;19:72-76 2019
- International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic Radiother Oncol. 2020 Jul;148:213-215 2020
- Treatment of Squamous Cell Carcinoma of the Anus, Unresolved Areas and Future Perspectives for Research: Perspectives of Research Needs in Anal Cancer. Clin Colorectal Cancer. 2021 Dec;20(4):279-287 2021
- Management of late adverse effects after chemoradiation for anal cancer Acta Oncol. 2021 Dec;60(12):1688-1701 2021
- Intensity modulated proton therapy planning study for organ at risk sparing in rectal cancer re-irradiation Acta Oncol. 2021 Nov;60(11):1436-1439 2021
- Anal cancer brachytherapy: From radon seeds to interstitial Papillon technique in a century. What does the future hold? Radiother Oncol. 2022 Apr;169:25-34 2022
- One-Year Treatment-Related Side Effects and Quality of Life After Chemoradiotherapy in Squamous Cell Carcinoma of the Anus Int J Radiat Oncol Biol Phys. 2022 Sep 28:S0360-3016(22)03395-8 2022